Icad Inc Stock Investor Sentiment

ICAD Stock  USD 1.97  0.07  3.68%   
About 55% of Icad's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding icad inc suggests that some traders are interested. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at finance.yahoo.com         
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
Yahoo News
few days ago at thelincolnianonline.com         
iCAD Stock Crosses Above 200-Day Moving Average Heres What Happened
news
six days ago at news.google.com         
iCAD Share Price Passes Above Two Hundred Day Moving Average - Heres Why - MarketBeat
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
iCAD Stock Crosses Above 200 Day Moving Average Should You Sell?
news
over a week ago at thelincolnianonline.com         
Acquisition by Doyle Michael John of 30000 shares of Icad at 2.06 subject to Rule 16b-3
news
over two weeks ago at thelincolnianonline.com         
Critical Contrast Todos Medical versus iCAD
news
over a month ago at kalkinemedia.com         
Icad Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer ...
news
over a month ago at globenewswire.com         
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial Calcifica...
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial ...
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial Calcifica...
Yahoo News
over a month ago at finance.yahoo.com         
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions ...
Yahoo News
over a month ago at gurufocus.com         
CORRECTION -- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI ...
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions ...
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a ...
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Secon...
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
11/05/2024
2
FDA clears AI-powered breast cancer detection tech from iCad
11/12/2024
3
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
11/13/2024
4
iCAD, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
5
iCAD, Inc. Sees Significant Growth in Short Interest
11/19/2024
6
CORRECTION -- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI ...
12/04/2024
7
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial ...
12/11/2024
8
Icad Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium
12/12/2024
9
iCAD Stock Crosses Above 200 Day Moving Average Should You Sell
01/03/2025
10
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
01/15/2025

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios